Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nanotubes, Carbon | 4 | 2016 | 23 | 1.200 |
Why?
|
| Phototherapy | 3 | 2016 | 52 | 0.680 |
Why?
|
| Polymers | 2 | 2016 | 63 | 0.630 |
Why?
|
| Cell Movement | 2 | 2016 | 169 | 0.620 |
Why?
|
| Hyperthermia, Induced | 3 | 2016 | 241 | 0.580 |
Why?
|
| Nanoparticles | 1 | 2016 | 51 | 0.530 |
Why?
|
| Decanoates | 1 | 2015 | 2 | 0.520 |
Why?
|
| Glycerol | 1 | 2015 | 5 | 0.520 |
Why?
|
| Nanocomposites | 1 | 2015 | 5 | 0.520 |
Why?
|
| Durapatite | 1 | 2015 | 9 | 0.520 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 215 | 0.460 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 308 | 0.450 |
Why?
|
| Cell Proliferation | 1 | 2015 | 604 | 0.440 |
Why?
|
| Cell Line, Tumor | 6 | 2016 | 725 | 0.390 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 765 | 0.330 |
Why?
|
| Collagen | 2 | 2016 | 225 | 0.240 |
Why?
|
| Cell Survival | 3 | 2016 | 279 | 0.160 |
Why?
|
| Nanomedicine | 2 | 2009 | 16 | 0.150 |
Why?
|
| Animals | 6 | 2016 | 7510 | 0.150 |
Why?
|
| Light | 1 | 2016 | 24 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 261 | 0.130 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2016 | 18 | 0.130 |
Why?
|
| Actins | 1 | 2016 | 51 | 0.130 |
Why?
|
| Cadherins | 1 | 2016 | 26 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2016 | 108 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2015 | 81 | 0.130 |
Why?
|
| Autophagy | 1 | 2016 | 52 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 64 | 0.130 |
Why?
|
| Mice | 3 | 2016 | 2474 | 0.120 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2015 | 182 | 0.110 |
Why?
|
| Water | 2 | 2009 | 56 | 0.100 |
Why?
|
| Rats | 1 | 2016 | 1592 | 0.100 |
Why?
|
| Ostreidae | 1 | 2009 | 1 | 0.090 |
Why?
|
| Fullerenes | 1 | 2009 | 3 | 0.090 |
Why?
|
| Embryonic Development | 1 | 2009 | 7 | 0.090 |
Why?
|
| Toxicity Tests | 1 | 2009 | 13 | 0.090 |
Why?
|
| Bacterial Capsules | 1 | 2009 | 4 | 0.080 |
Why?
|
| Microscopy, Atomic Force | 1 | 2009 | 5 | 0.080 |
Why?
|
| Bacterial Adhesion | 1 | 2009 | 6 | 0.080 |
Why?
|
| Dermis | 1 | 2009 | 16 | 0.080 |
Why?
|
| Cell Size | 1 | 2009 | 38 | 0.080 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2009 | 9 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2009 | 53 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2009 | 91 | 0.080 |
Why?
|
| Female | 2 | 2016 | 19999 | 0.070 |
Why?
|
| Fas Ligand Protein | 1 | 2007 | 7 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2007 | 11 | 0.070 |
Why?
|
| Cisplatin | 1 | 2007 | 76 | 0.070 |
Why?
|
| Mesothelioma | 1 | 2007 | 39 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 245 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2009 | 201 | 0.070 |
Why?
|
| Humans | 5 | 2016 | 32082 | 0.070 |
Why?
|
| Reactive Oxygen Species | 1 | 2007 | 157 | 0.070 |
Why?
|
| Apoptosis | 1 | 2007 | 353 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 943 | 0.050 |
Why?
|
| Neoplasms | 1 | 2007 | 728 | 0.040 |
Why?
|
| Temperature | 2 | 2009 | 55 | 0.040 |
Why?
|
| Infrared Rays | 2 | 2009 | 18 | 0.040 |
Why?
|
| Models, Biological | 2 | 2009 | 392 | 0.030 |
Why?
|
| Hepatopancreas | 1 | 2009 | 1 | 0.020 |
Why?
|
| Embryo, Nonmammalian | 1 | 2009 | 4 | 0.020 |
Why?
|
| Lysosomes | 1 | 2009 | 10 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2009 | 33 | 0.020 |
Why?
|
| Surface Properties | 1 | 2009 | 32 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 33 | 0.020 |
Why?
|
| Osmotic Pressure | 1 | 2009 | 10 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2009 | 83 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2009 | 67 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 208 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 215 | 0.020 |
Why?
|
| Caspase 8 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2007 | 34 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 66 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 114 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2007 | 290 | 0.020 |
Why?
|
| Mitochondria | 1 | 2007 | 185 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2007 | 680 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 606 | 0.010 |
Why?
|